B. Kasimis

发表

Social construction of the rural environment. Europe and discourses in France, Germany and Portugal.

M. Redclift, K. Bruckmeier, J. Billaud, 1997 .

M. Redclift, H. D. Haan, B. Kasimis, 1997 .

Prediction of Survival for Advanced Cancer Patients by Recursive Partitioning Analysis: Role of Karnofsky Performance Status, Quality of Life, and Symptom Distress

C. Scott, Charles B Scott, Shirley S Hwang, 2004, Cancer investigation.

Symptom and quality of life survey of medical oncology patients at a Veterans Affairs medical center

M. Feuerman, B. Kasimis, Shirley S. Hwang, 2000, Cancer.

Study of Hormone Refractory Prostate Cancer: Hospital Care and Palliative Care Resource Use at a VA Medical Center

B. Kasimis, Shirley S. Hwang, V. Chang, 2004, Cancer investigation.

Survival of Patients Who Had Salvage Castration After Failure on Bicalutamide Monotherapy for Stage (D2) Prostate Cancer

G. Wilding, C. Rae, M. Feuerman, 2000, Cancer investigation.

Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma.

G. Kennealey, G. Chodak, N. Block, 1995, Urology.

A retrospective analysis of cardiovascular morbidity in metastatic hormone-refractory prostate cancer patients on high doses of the selective COX-2 inhibitor celecoxib

R. Madan, B. Kasimis, R. Oriscello, 2007, Expert opinion on pharmacotherapy.

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.

R. Schilsky, N. Kemeny, D. Haller, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

The clinical significance of radiographically detected pulmonary neoplastic lesions in patients with head and neck cancer.

R. B. Wuerker, B. Kasimis, E. Moran, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Giant malignant melanoma of the anterior chest wall with widespread metastasis

V. Chang, N. Duma, B. Kasimis, 2015 .

Asymptomatic mantle cell lymphoma in the trachea

B. Kasimis, V. Chang, S. Srinivas, 2009, Leukemia & lymphoma.

Taxol in advanced, hormone‐refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group

B. Yeap, G. Wilding, B. Roth, 1993, Cancer.

Bicalutamide in Advanced Prostate Cancer

F. Boccardo, P. Iversen, B. Kasimis, 1998 .

Chronic anemia progressing to auer rod‐positive and TdT‐positive acute leukemia with 5q– chromosomal anomaly

B. Kasimis, A. Xavier, 1984, American journal of hematology.

Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer.

P. Schein, C. Blanke, M. Kurman, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.

J. Hainsworth, D. Gandara, P. Hesketh, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Trial of Alternating Chemotherapy in Patients with Inoperable Non‐Small Cell Lung Cancer

B. Kasimis, L. Howard, E. Cramer, 1994, American journal of clinical oncology.

Rural tourism and sustainable development: a case study on Slovenia.

M. Redclift, H. D. Haan, B. Kasimis, 1997 .

Development of a cancer pain prognostic scale.

D. Fairclough, Shirley S Hwang, Victor T Chang, 2002, Journal of pain and symptom management.

Primary Carcinoma of the Renal Pelvis and Ureter

B. Kasimis, 1982 .

Multidimensional independent predictors of cancer-related fatigue.

B. Kasimis, Shirley S. Hwang, V. Chang, 2003, Journal of pain and symptom management.

Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.

K. A. Forbes, B. Kasimis, J. Miller, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.

K. A. Forbes, B. Kasimis, J. Miller, 1983, Cancer treatment reports.

The Memorial Symptom Assessment Scale Short Form (MSAS‐SF)

H. Thaler, V T Chang, S S Hwang, 2000, Cancer.

Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancer.

G. Shapiro, R. Bukowski, P. Schwarzenberger, 2008, Clinical lung cancer.

A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.

B. Kasimis, W. Hahne, P. Schulman, 1997, Cancer investigation.

Multiple Myeloma Associated with Myelofibrosis

R. Neiman, B. Kasimis, R. Yen-Lin, 1981 .

Caregiver unmet needs, burden, and satisfaction in symptomatic advanced cancer patients at a Veterans Affairs (VA) medical center

Shirley S Hwang, Victor T Chang, Janet Cogswell, 2003, Palliative and Supportive Care.

Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model.

B. Kasimis, V. Chang, J. Cogswell, 2004, Journal of pain and symptom management.

Durable response of angiosarcoma of the face and scalp to docetaxel.

V. Chang, B. Kasimis, J. Choe, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical cancer center.

D. Fairclough, B. Kasimis, V. Chang, 2003, Journal of pain and symptom management.

Cancer breakthrough pain characteristics and responses to treatment at a VA medical center

B. Kasimis, V. Chang, S. Hwang, 2003, Pain.

Prolonged survival of patients with extrapulmonary small cell carcinoma arising in the neck.

R. B. Wuerker, B. Kasimis, E. Moran, 1983, Medical and pediatric oncology.

THROMBOTIC COMPLICATIONS IN PATIENTS WITH ADVANCED PROSTATIC CANCER TREATED WITH CHEMOTHERAPY

B. Kasimis, A. Spiers, 1979, The Lancet.

Longitudinal documentation of cancer pain management outcomes: a pilot study at a VA medical center.

B. Kasimis, V. Chang, S. Hwang, 2002, Journal of pain and symptom management.

Dynamic cancer pain management outcomes: the relationship between pain severity, pain relief, functional interference, satisfaction and global quality of life over time.

B. Kasimis, V. Chang, S. Hwang, 2002, Journal of pain and symptom management.

Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center

B. Kasimis, V. Chang, J. Cogswell, 2002, Cancer.

Prognostic value of soft tissue metastasis (STM) in stage D2 and stage D3 prostate Cancer (PC)

R. Madan, B. Kasimis, V. Chang, 2005 .

Shorter Symptom Assessment Instruments: The Condensed Memorial Symptom Assessment Scale (CMSAS)

H. Thaler, B. Kasimis, V. Chang, 2004, Cancer investigation.

The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.

B. Kasimis, V. Chang, Q. Xia, 2005, The journal of supportive oncology.

Memorial Symptom Assessment Scale

H. Thaler, R. Portenoy, B. Kasimis, 2004, Expert review of pharmacoeconomics & outcomes research.

Primary Carcinomas of the Male and Female Urethra: Other Rare Forms of Urothelial Cancer

B. Kasimis, 1982 .

A Comparison Of Three Fatigue Measures In Veterans With Cancer

B. Kasimis, V. Chang, S. Hwang, 2003, Cancer investigation.

Side effects and good effects from new chemotherapeutic agents. Case 1. Gefitinib-induced interstitial fibrosis.

B. Kasimis, J. Cogswell, J. Choe, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient-Reported Outcomes for Determining Prognostic Groups in Veterans With Advanced Cancer.

C. Scott, J. Einhorn, B. Kasimis, 2010, Journal of pain and symptom management.

The adoption of alternative farming enterprises in Ireland's less favoured areas.

M. Redclift, D. Gillmor, M. Cawley, 1997 .

Renal effects of high-dose celecoxib (CX) and docetaxel (D) During a phase II trial for hormone resistant prostate cancer (HRPC).

B. Kasimis, V. Chang, S. Srinivas, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Memorial Symptom Assessment Scale--Short Form

H. Thaler, M. Feuerman, B. Kasimis, 2015 .

Second line treatment of hormone resistant prostate cancer (HRPC). A phase II trial of epirubicin (E), estramustine phosphate (EP) and celecoxib (C)

M. Ohanian, B. Kasimis, V. Chang, 2005 .

High dose celecoxib (C) and docetaxel (D) in patients (pts) with hormone resistant prostate cancer (HRPC). Results of an ongoing phase II trial

B. Kasimis, V. Chang, J. Cogswell, 2005 .

Waldenstrom's macroglobulinemia evolving into acute lymphoblastic leukemia: a case report and a review of the literature

R. Madan, B. Kasimis, V. Chang, 2004, Leukemia.

Knowledge and attitudes toward end-of-life care in veterans with symptomatic metastatic cancer

B. Kasimis, V. Chang, J. Cogswell, 2003, Palliative and Supportive Care.

Relationship between changes in the histologic subtype of small cell carcinoma of the lung and the response to chemotherapy.

R. B. Wuerker, J. D. Hunt, B. Kasimis, 1986, American journal of clinical oncology.

Phase II study of DHA-paclitaxel (TXP) as first line chemotherapy in patients with hormone refractory prostate cancer (HRPC)

M. Carducci, D. Petrylak, M. Doukas, 2004 .

Good tolerance to high‐dose hepatic arterial infusion therapy

A. Wile, P. Iyer, B. Kasimis, 1986, Journal of surgical oncology.

Carcinoid syndrome in the absence of liver metastasis: a case report and review of literature.

B. Kasimis, A. U. Haq, C. Yook, 1992, Medical and pediatric oncology.

Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center

B. Kasimis, V. Chang, J. Cogswell, 2002, Cancer.